Biolife Sciences Stock Net Income
| BLFE Stock | USD 0.0001 0.00 0.00% |
BioLife Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
BioLife Sciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing BioLife Sciences' valuation are provided below:BioLife Sciences does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. BioLife |
BioLife Sciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioLife Sciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioLife Sciences.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in BioLife Sciences on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding BioLife Sciences or generate 0.0% return on investment in BioLife Sciences over 90 days. Bio Life Sciences Corp. develops, licenses, and distributes antibacterial products and non-contact human temperature scr... More
BioLife Sciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioLife Sciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioLife Sciences upside and downside potential and time the market with a certain degree of confidence.
BioLife Sciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioLife Sciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioLife Sciences' standard deviation. In reality, there are many statistical measures that can use BioLife Sciences historical prices to predict the future BioLife Sciences' volatility.BioLife Sciences Backtested Returns
We have found three technical indicators for BioLife Sciences, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and BioLife Sciences are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
BioLife Sciences has perfect predictability. Overlapping area represents the amount of predictability between BioLife Sciences time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioLife Sciences price movement. The serial correlation of 1.0 indicates that 100.0% of current BioLife Sciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, BioLife Sciences reported net income of (456,868). This is 100.13% lower than that of the Healthcare sector and 100.46% lower than that of the Medical Instruments & Supplies industry. The net income for all United States stocks is 100.08% higher than that of the company.
BioLife Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioLife Sciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BioLife Sciences could also be used in its relative valuation, which is a method of valuing BioLife Sciences by comparing valuation metrics of similar companies.BioLife Sciences is currently under evaluation in net income category among its peers.
BioLife Fundamentals
| Current Valuation | 1.01 M | |||
| Price To Sales | 0 X | |||
| Net Income | (456.87 K) | |||
| Cash And Equivalents | 15.62 K | |||
| Total Debt | 398 K | |||
| Current Ratio | 0.07 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (106.55 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 0.0763 | |||
| Market Capitalization | 11.45 K |
About BioLife Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioLife Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioLife Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioLife Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BioLife Pink Sheet
BioLife Sciences financial ratios help investors to determine whether BioLife Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLife with respect to the benefits of owning BioLife Sciences security.